BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 29091862)

  • 1. The anti-hyperuricemic effect of epigallocatechin-3-gallate (EGCG) on hyperuricemic mice.
    Zhu C; Xu Y; Liu ZH; Wan XC; Li DX; Tai LL
    Biomed Pharmacother; 2018 Jan; 97():168-173. PubMed ID: 29091862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin gallate reduces uric acid levels by regulating xanthine oxidase activity and uric acid excretion in vitro and in vivo.
    Li F; Liu Y; Xie Y; Liu Z; Zou G
    Ann Palliat Med; 2020 Mar; 9(2):331-338. PubMed ID: 32008337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate.
    Xie Q; Cai X; Dong X; Wang Y; Sun M; Tai L; Xu Y
    Pharm Biol; 2021 Dec; 59(1):157-166. PubMed ID: 33556300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of epigallocatechin gallate (EGCG) in ameliorating hyperuricemia: insights into gut microbiota and intestinal function in a mouse model.
    Yu H; Lou Z; Wu T; Wan X; Huang H; Wu Y; Li B; Tu Y; He P; Liu J
    Food Funct; 2024 Jun; 15(11):6068-6081. PubMed ID: 38757391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of green and black tea extracts on lowering serum uric acid in hyperuricemic mice.
    Zhu C; Tai LL; Wan XC; Li DX; Zhao YQ; Xu Y
    Pharm Biol; 2017 Dec; 55(1):2123-2128. PubMed ID: 28938867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
    Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
    Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1.
    Oh DR; Kim JR; Choi CY; Choi CH; Na CS; Kang BY; Kim SJ; Kim YR
    BMC Complement Altern Med; 2019 Jan; 19(1):10. PubMed ID: 30621705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.
    Chen G; Tan ML; Li KK; Leung PC; Ko CH
    J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypouricemic and Nephroprotective Effects of an Active Fraction from Polyrhachis Vicina Roger On Potassium Oxonate-Induced Hyperuricemia in Rats.
    Su Q; Su H; Nong Z; Li D; Wang L; Chu S; Liao L; Zhao J; Zeng X; Ya Q; He F; Lu W; Wei B; Wei G; Chen N
    Kidney Blood Press Res; 2018; 43(1):220-233. PubMed ID: 29490297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1.
    Hu Q; Zhou M; Zhu H; Lu G; Zheng D; Li H; Hao K
    Biomed Pharmacother; 2017 Feb; 86():88-94. PubMed ID: 27951420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pallidifloside D, a saponin glycoside constituent from Smilax riparia, resist to hyperuricemia based on URAT1 and GLUT9 in hyperuricemic mice.
    Wu XH; Ruan JL; Zhang J; Wang SQ; Zhang YW
    J Ethnopharmacol; 2014 Nov; 157():201-5. PubMed ID: 25267580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypouricemic Effect of 2,5-Dihydroxyacetophenone, a Computational Screened Bioactive Compound from
    Liang D; Yong T; Chen S; Xie Y; Chen D; Zhou X; Li D; Li M; Su L; Zuo D
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice.
    Wang R; Ma CH; Zhou F; Kong LD
    Chin J Nat Med; 2016 Jul; 14(7):499-507. PubMed ID: 27507200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxyberberrubine, a novel liver microsomes-mediated secondary metabolite of berberine, alleviates hyperuricemic nephropathy in mice.
    Zhong L; Lin Y; Gong S; Wu X; Liu Y; Chen J; Li Y; Yan F; Su Z; Xie Q
    Phytomedicine; 2023 Jan; 108():154521. PubMed ID: 36334387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.
    Li Y; Zhao Z; Luo J; Jiang Y; Li L; Chen Y; Zhang L; Huang Q; Cao Y; Zhou P; Wu T; Pang J
    Phytomedicine; 2021 Jul; 87():153585. PubMed ID: 34044255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypouricemic and nephroprotective roles of anthocyanins in hyperuricemic mice.
    Qian X; Wang X; Luo J; Liu Y; Pang J; Zhang H; Xu Z; Xie J; Jiang X; Ling W
    Food Funct; 2019 Feb; 10(2):867-878. PubMed ID: 30693917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production Inhibition and Excretion Promotion of Urate by Fucoidan from
    Zhang D; Liu H; Luo P; Li Y
    Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30486413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeic acid phenethyl ester alleviated hypouricemia in hyperuricemic mice through inhibiting XOD and up-regulating OAT3.
    Yong T; Liang D; Chen S; Xiao C; Gao X; Wu Q; Xie Y; Huang L; Hu H; Li X; Liu Y; Cai M
    Phytomedicine; 2022 Aug; 103():154256. PubMed ID: 35714456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gypenosides Inhibits Xanthine Oxidoreductase and Ameliorates Urate Excretion in Hyperuricemic Rats Induced by High Cholesterol and High Fat Food (Lipid Emulsion).
    Pang M; Fang Y; Chen S; Zhu X; Shan C; Su J; Yu J; Li B; Yang Y; Chen B; Liang K; Hu H; Lv G
    Med Sci Monit; 2017 Mar; 23():1129-1140. PubMed ID: 28258276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice.
    Xu L; Lin G; Yu Q; Li Q; Mai L; Cheng J; Xie J; Liu Y; Su Z; Li Y
    Front Pharmacol; 2021; 12():645879. PubMed ID: 33959014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.